Long-term use of low-dose aspirin following a diagnosis of prostate cancer may decrease the risk of dying from the disease
Time from definitive therapy to onset of metastatic disease predicts outcomes in men with metastatic hormone sensitive prostate cancer
In men with new Metastatic Hormone-sensitive prostate cancer, time from definitive therapy to initiation of androgen deprivation therapy (<5 vs. ≥5 years) is predictive of time to Castration-resistant Prostate Cancer on Androgen Deprivation Therapy.
Higher spot urine sodium-to-potassium ratios are associated with increased stroke risk
The online calculator presents multiple outcomes and can serve as a platform to inform treatment selection in men with localized prostate cancer.
Individuals who take proton pump inhibitors (PPIs) are at increased risk of kidney damage. This relationship could have considerable public health impact; therefore, health care provider education and deprescribing initiatives will be necessary to raise awareness and reduce health care burden
Rates of some obesity-related cancers are rising faster in adults aged 25 to 49 than in older generations and the future burden of cancer in this population could halt or reverse decades of progress achieved in lowering cancer mortality
According to a recent systematic review of the latest literature, the higher surgical volume is associated with improved outcomes for radical prostatectomy.
High dietary intake of zinc, a key trace element in normal prostate cell metabolism, may be associated with an elevated risk of low-grade prostate cancer (PCa), a new study suggests.